Bendamustine supercharge plus brentuximab vedotin as early salvage therapy following failure to obtain complete metabolic remission after two cycles of adriamycin-bleomycin-vinblastine-dacarbazine for classic Hodgkin lymphoma in patients aged ≤ 60 years: Long-term efficacy results of a retrospective multicentre study.

IF 5.1 2区医学 Q1 HEMATOLOGY

British Journal of Haematology Pub Date : 2025-04-02 DOI:10.1111/bjh.20053

C Giordano, M Picardi, N Pugliese, A Vincenzi, S Avilia, L De Fazio, M Lamagna, R Reina, A Scarpa, A Lombardi, E Vigliar, G Troncone, M Mascolo, C Mainolfi, R Fonti, S Del Vecchio, V Damiano, R Bianco, F Trastulli, M Annunziata, A Salemme, M Carchia, F Pane

引用次数: 0

查看原文本刊更多论文

对于年龄≤60岁的经典霍奇金淋巴瘤患者，阿霉素-博莱霉素-长春花碱-达卡巴嗪两个周期治疗后未能获得完全代谢缓解，苯达莫司汀增压加布伦妥昔单抗韦多汀作为早期补救性治疗：一项回顾性多中心研究的长期疗效结果

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

British Journal of Haematology 医学-血液学

CiteScore

8.60

自引率

4.60%

发文量

565

审稿时长

1 months

期刊介绍： The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.